{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:05:11Z","timestamp":1785769511687,"version":"3.56.0"},"reference-count":67,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Psoriasis is one of the most common skin diseases in dermatological practice. It affects about 1\u20133% of the general population and is associated with different comorbidities, especially metabolic syndrome. Fatty-acid-binding proteins (FABPs) are a family of cytosolic proteins which are an important link in lipid metabolism and transport; moreover, they have different tissue specificity and properties. So far, ten FABPs have been discovered and seven have been investigated in psoriasis. In this review, we discuss the nature of all FABPs and their role in psoriasis. FABPs have different organ and tissue expression, and hence various functions, and may be markers of different disorders. Considering the concentration of a few of them tends to be elevated in psoriasis, it confirms the current perception of psoriasis as a multiorgan disorder associated with plenty of comorbidities. Some FABPs may be also further investigated as biomarkers of psoriasis organ complications. FABP-1 and FABP-5 may become potential markers of metabolic complications and inflammation in psoriasis. FABP-7 could perhaps be further investigated as an indicator of the neurodegenerative processes in psoriatic patients.<\/jats:p>","DOI":"10.3390\/metabo12090833","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T22:33:01Z","timestamp":1662503581000},"page":"833","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Fatty Acid-Binding Proteins in Psoriasis\u2014A Review"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6870-1167","authenticated-orcid":false,"given":"Julia","family":"Nowowiejska","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, Zurawia 14 St., 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8018-9960","authenticated-orcid":false,"given":"Anna","family":"Baran","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, Zurawia 14 St., 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Flisiak","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, Zurawia 14 St., 15-540 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,3]]},"reference":[{"key":"ref_1","unstructured":"Psoriasis Statistics (2022, June 01). The National Psoriasis Foundation. Available online: https:\/\/www.psoriasis.org\/psoriasis-statistics\/."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hirotsu, C., Rydlewski, M., Ara\u00fajo, M.S., Tufik, S., and Andersen, M.L. (2012). Sleep loss and cytokines levels in an experimental model of psoriasis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051183"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Tokuyama, M., and Mabuchi, T. (2020). New Treatment Addressing the Pathogenesis of Psoriasis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207488"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5455\/medarh.2021.75.31-34","article-title":"Comorbidity in Men with Psoriasis","volume":"75","author":"Salihbegovic","year":"2021","journal-title":"Med. Arch."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1574886315666200128095958","article-title":"Treatment of Psoriasis: A Comprehensive Review of Entire Therapies","volume":"15","author":"Bakshi","year":"2020","journal-title":"Curr. Drug Saf."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","volume":"80","author":"Elmets","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.det.2014.09.004","article-title":"Psoriasis Is a Systemic Disease with Multiple Cardiovascular and Metabolic Comorbidities","volume":"33","author":"Ryan","year":"2015","journal-title":"Dermatol. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: Epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"711060","DOI":"10.3389\/fimmu.2021.711060","article-title":"Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions","volume":"12","author":"Hao","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ad.2012.08.003","article-title":"Obesity and psoriasis: Inflammatory nature of obesity, relationship between psoriasis and obesity, and therapeutic implications","volume":"105","author":"Carrascosa","year":"2014","journal-title":"Actas Dermosifiliogr."},{"key":"ref_11","first-page":"623","article-title":"Clofibrate treatment of psoriasis with hypertriglycemia\u2013clinical, histological and laboratory analysis","volume":"101","author":"Imamura","year":"1991","journal-title":"Nihon Hifuka Gakkai Zasshi"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3889\/oamjms.2019.060","article-title":"Efficacy of adding oral simvastatin to topical therapy for treatment of psoriasis: The vietnamese experience","volume":"7","author":"Trong","year":"2019","journal-title":"Open Access Maced. J. Med. Sci"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jdv.15211","article-title":"Role of galectin-3 in subclinical myocardial impairment in psoriasis","volume":"33","author":"Kotwica","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kiluk, P., Baran, A., Kaminski, T.W., Maciaszek, M., and Flisiak, I. (2019). The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients. J. Clin. Med., 8.","DOI":"10.3390\/jcm8122206"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.cell.2020.07.027","article-title":"SnapShot: FABP Functions","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1479-7364-5-3-170","article-title":"The human fatty acid-binding protein family: Evolutionary divergences and functions","volume":"5","author":"Smathers","year":"2011","journal-title":"Hum. Genom."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bpj.2019.12.005","article-title":"Ligand Entry into Fatty Acid Binding Protein via Local Unfolding Instead of Gap Widening","volume":"118","author":"Xiao","year":"2020","journal-title":"Biophys. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1194\/jlr.R800084-JLR200","article-title":"Structural and functional analysis of fatty acid-binding proteins","volume":"50","author":"Storch","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00436-022-07463-1","article-title":"Function of lipid binding proteins of parasitic helminths: Still a long road","volume":"121","author":"Lombardo","year":"2022","journal-title":"Parasitol. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11745-016-4211-4","article-title":"Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis","volume":"52","author":"Baran","year":"2017","journal-title":"Lipids."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00403-019-01917-w","article-title":"Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis","volume":"311","author":"Baran","year":"2019","journal-title":"Arch. Dermatol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.5604\/17322693.966983","article-title":"Znaczenie kliniczne bia\u0142ek wi\u0105\u017c\u0105cych kwasy t\u0142uszczowe (FABPs) [The clinical significance of fatty acid binding proteins]","volume":"65","author":"Dadan","year":"2011","journal-title":"Postepy Hig. Med. Dosw."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00059-012-3714-x","article-title":"Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis","volume":"38","author":"Akbal","year":"2013","journal-title":"Herz"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Shi, J., Zhang, Y., Gu, W., Cui, B., Xu, M., Yan, Q., Wang, W., Ning, G., and Hong, J. (2012). Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in Chinese young adults. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048777"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","article-title":"The concept of psoriasis as a systemic inflammation: Implications for disease management","volume":"26","author":"Reich","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpsychires.2019.10.002","article-title":"Increased ileal bile acid binding protein and galectin-9 are associated with mild cognitive impairment and Alzheimer\u2019s disease","volume":"119","author":"Wang","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Sikora, M., Stec, A., Chrabaszcz, M., Waskiel-Burnat, A., Zaremba, M., Olszewska, M., and Rudnicka, L. (2019). Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis. J. Clin. Med., 8.","DOI":"10.3390\/jcm8071021"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1007\/s00268-017-4124-2","article-title":"I-FABP is a Novel Marker for the Detection of Intestinal Injury in Severely Injured Trauma Patients","volume":"41","author":"Voth","year":"2017","journal-title":"World J. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Guedj, K., Uzzan, M., Soudan, D., Trichet, C., Nicoletti, A., Weiss, E., Manceau, H., Nuzzo, A., Corcos, O., and Treton, X. (2021). I-FABP is decreased in COVID-19 patients, independently of the prognosis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0249799"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/1346-8138.14647","article-title":"Intestinal barrier integrity in patients with plaque psoriasis","volume":"45","author":"Sikora","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1074\/jbc.M110.184754","article-title":"Heart-type fatty acid-binding protein is essential for efficient brown adipose tissue fatty acid oxidation and cold tolerance","volume":"286","author":"Vergnes","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_32","first-page":"124","article-title":"Role of Gal-3 and H-FABP in the early diagnosis of acute coronary syndrome","volume":"120","author":"Atay","year":"2019","journal-title":"Bratisl. Lek. Listy"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2217\/bmm-2019-0134","article-title":"Biomarkers in diagnosing and treatment of acute heart failure","volume":"13","author":"Pourafkari","year":"2019","journal-title":"Biomark. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000491819","article-title":"Decreased Systemic Levels of Endocan-1 and CXCL16 in Psoriasis Are Restored Following Narrowband UVB Treatment","volume":"234","author":"Sigurdardottir","year":"2018","journal-title":"Dermatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.106.647503","article-title":"Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: A 5-year prospective study","volume":"115","author":"Xu","year":"2007","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5551\/jat.48710","article-title":"Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases","volume":"26","author":"Furuhashi","year":"2019","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/lipd.12173","article-title":"Adipocyte Fatty Acid-Binding Protein as a Novel Marker of Psoriasis and Clinical Response to Acitretin","volume":"54","author":"Baran","year":"2019","journal-title":"Lipids"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e00303","DOI":"10.1042\/BSR20150281","article-title":"Gender difference in plasma fatty acid-binding protein 4 levels in patients with chronic obstructive pulmonary disease","volume":"36","author":"Zhang","year":"2016","journal-title":"Biosci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/joim.13447","article-title":"The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast","volume":"291","author":"Ruiz","year":"2022","journal-title":"J. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Krahel, J.A., Baran, A., Kami\u0144ski, T.W., Maciaszek, M., and Flisiak, I. (2020). Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data. J. Clin. Med., 9.","DOI":"10.3390\/jcm9040910"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1111\/1346-8138.14638","article-title":"Serum fatty acid-binding protein 4 level is inversely correlated with serum thymus and activation-regulated chemokine level in psoriatic patients achieving clear skin by biologics","volume":"46","author":"Honma","year":"2019","journal-title":"J. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/exd.12111","article-title":"E-FABP induces differentiation in normal human keratinocytes and modulates the differentiation process in psoriatic keratinocytes in vitro","volume":"22","author":"Dallaglio","year":"2013","journal-title":"Exp. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jdermsci.2012.09.002","article-title":"Epidermal-type FABP is a predictive marker of clinical response to systemic treatment and ultraviolet therapy in psoriatic skin lesions","volume":"68","author":"Miyake","year":"2012","journal-title":"J. Dermatol. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1007\/s11033-021-06461-3","article-title":"Serum fatty acid binding protein 5 (FABP5) as a potential biomarker of inflammation in psoriasis","volume":"48","author":"Milewska","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000246367","article-title":"Epidermal fatty-acid-binding protein in psoriasis, basal and squamous cell carcinomas: An immunohistological study","volume":"192","author":"Masouye","year":"1996","journal-title":"Dermatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1158\/1078-0432.CCR-05-2045","article-title":"Fatty acid binding protein 6 is overexpressed in colorectal cancer","volume":"12","author":"Ohmachi","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"T\u00f6lle, A., Suhail, S., Jung, M., Jung, K., and Stephan, C. (2011). Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma. BMC Cancer, 11.","DOI":"10.1186\/1471-2407-11-302"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.jid.2018.02.003","article-title":"Bioactive Lipid Mediator Profiles in Human Psoriasis Skin and Blood","volume":"138","author":"Sorokin","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1267\/ahc.20001","article-title":"Fatty Acid Binding Protein 7 is Involved in the Proliferation of Reactive Astrocytes, but not in Cell Migration and Polarity","volume":"53","author":"Hara","year":"2020","journal-title":"Acta Histochem. Cytochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/dneu.22314","article-title":"Fatty acid binding protein 7 and n-3 poly unsaturated fatty acid supply in early rat brain development","volume":"76","author":"Maximin","year":"2016","journal-title":"Dev. Neurobiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000440839","article-title":"Oxidized Docosahexaenoic Acid Species and Lipid Peroxidation Products Increase Amyloidogenic Amyloid Precursor Protein Processing","volume":"16","author":"Grimm","year":"2016","journal-title":"Neurodegener. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1590\/1806-9282.20200784","article-title":"Relations of heart-type and brain-type fatty acid-binding proteins with postoperative cognitive dysfunction in elderly patients undergoing spinal surgery","volume":"67","author":"Jiang","year":"2021","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ajmg.b.31004","article-title":"Association analyses between brain-expressed fatty-acid binding protein (FABP) genes and schizophrenia and bipolar disorder","volume":"153B","author":"Iwayama","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Watanabe, A., Toyota, T., Owada, Y., Hayashi, T., Iwayama, Y., Matsumata, M., Ishitsuka, Y., Nakaya, A., Maekawa, M., and Ohnishi, T. (2007). Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol., 5.","DOI":"10.1371\/journal.pbio.0050297"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.plipres.2013.08.004","article-title":"Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma","volume":"52","author":"Elsherbiny","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"T\u00f6lle, A., Jung, M., Lein, M., Johannsen, M., Miller, K., Moch, H., Jung, K., and Kristiansen, G. (2009). Brain-type and liver-type fatty acid-binding proteins: New tumor markers for renal cancer?. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-248"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e1602663","DOI":"10.1126\/sciadv.1602663","article-title":"Normal sleep requires the astrocyte brain-type fatty acid binding protein FABP7","volume":"3","author":"Gerstner","year":"2017","journal-title":"Sci. Adv."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Nowowiejska, J., Baran, A., Hermanowicz, J.M., Sieklucka, B., Krahel, J.A., Kiluk, P., Pawlak, D., and Flisiak, I. (2022). Fatty Acid-Binding Protein 7 (FABP-7), Glutamic Acid and Neurofilament Light Chain (NFL) as Potential Markers of Neurodegenerative Disorders in Psoriatic Patients\u2014A Pilot Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11092430"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10571-017-0494-0","article-title":"The Role of Peripheral Myelin Protein 2 in Remyelination","volume":"38","author":"Stettner","year":"2018","journal-title":"Cell Mol. Neurobiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ijbiomac.2017.03.100","article-title":"Role of enzymatic free radical scavengers in management of oxidative stress in autoimmune disorders","volume":"101","author":"Srivastava","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ygeno.2008.08.003","article-title":"A novel fatty acid-binding protein (FABP) gene resulting from tandem gene duplication in mammals: Transcription in rat retina and testis","volume":"92","author":"Liu","year":"2008","journal-title":"Genomics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.immuni.2015.04.016","article-title":"Epidermal Fatty Acid binding protein promotes skin inflammation induced by high-fat diet","volume":"42","author":"Zhang","year":"2015","journal-title":"Immunity"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/eurheartj\/ehn295","article-title":"Epidermal fatty-acid-binding protein: A new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis","volume":"29","author":"Yeung","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"508","DOI":"10.5114\/dr.2020.103887","article-title":"Psoriasis and cardiometabolic disorders","volume":"107","author":"Nowowiejska","year":"2020","journal-title":"Dermatol. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/13543776.2016.1182500","article-title":"Fatty acid binding protein (FABP) inhibitors: A patent review (2012\u20132015)","volume":"26","author":"Wang","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2174\/1381612828666220527141532","article-title":"Differential impact of biologic therapy on heart function biomarkers in rheumatoid arthritis patients: Observational study on etanercept, adalimumab and tocilizumab","volume":"28","author":"Nowak","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"106318","DOI":"10.1016\/j.phrs.2022.106318","article-title":"Topical VX-509 attenuates psoriatic inflammation through the STAT3\/FABP5 pathway in keratinocytes","volume":"182","author":"Yan","year":"2022","journal-title":"Pharmacol. Res."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/12\/9\/833\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:22:53Z","timestamp":1760142173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/12\/9\/833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,3]]},"references-count":67,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["metabo12090833"],"URL":"https:\/\/doi.org\/10.3390\/metabo12090833","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,3]]}}}